Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver

IMPORTANCE: As opioid-related deaths continue to climb, methods to reduce barriers to prescribing buprenorphine for individuals with opioid use disorder (OUD) are needed. Recent conversations by state and federal authorities targeting low-threshold buprenorphine aim to reduce some barriers to prescr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanham, Holly J., Papac, Jennifer, Olmos, Daniela I., Heydemann, Emily L., Simonetti, Nathalia, Schmidt, Susanne, Potter, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099423/
https://www.ncbi.nlm.nih.gov/pubmed/35552721
http://dx.doi.org/10.1001/jamanetworkopen.2022.12419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099423/
https://www.ncbi.nlm.nih.gov/pubmed/35552721
http://dx.doi.org/10.1001/jamanetworkopen.2022.12419

Ejemplares similares